| |
| Trade Name | XIENCE AND PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEMS |
| Classification Name | coronary drug-eluting stent |
| Generic Name | drug eluting coronary stent system |
| Applicant | ABBOTT VASCULAR INC. |
| PMA Number | P070015 |
| Date Received | 06/01/2007 |
| Decision Date | 07/02/2008 |
| Product Code | |
| Docket Number | 08M-0535 |
| Notice Date | 10/07/2008 |
| Advisory Committee |
Cardiovascular |
| Expedited Review Granted? | No |
| Combination Product |
Yes
|
| Information About: |
Labeling, Approval Order, Summary of Safety and Effectiveness |
Approval Order Statement Approval for the xience v everolimus eluting coronary stent system, which will also be distributed as the promus everolimus eluting coronary stent system. This device is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (length <= 28 mm) with reference vessel diameters of 2. 5 mm to 4. 25 mm. |
| Approval Order |
Approval Order
|
| Post-Approval Study | Show Report Schedule and Study Progress |
| Supplements: |
S001 S002 S003 S004 S005 S006 S007 S008 S010 S011 S012 S013 S014 S015 S016 S017 S018 S019 S020 S021 S022 S023 S024 S025 S026 S027 S028 S029 S031 S032 S033 S034 S035 S036 S037 S038 S039 S040 S041 S042 S043 S044 S045 S046 S047 S048 S050 S051 S052 S053 S054 S055 S056 S058 S059 S060 S061 S062 S063 S064 S065 S066 S067 S068 S069 S070 S071 S072 S074 S075 S076 S077 S078 S079 S080 S081 S082 S083 S085 S086 S087 S088 S089 S090 S091 S092 S093 S094 S096 S097 S098 S099 S101 S102 S104 S106
|